Escalation strategies for combination therapy Phase I trials.
about
A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic data.Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.Adaptive designs for dual-agent phase I dose-escalation studies.Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycle.A product of independent beta probabilities dose escalation design for dual-agent phase I trials.Effect of design specifications in dose-finding trials for combination therapies in oncology.A Bayesian dose-finding design for drug combination clinical trials based on the logistic model.
P2860
Q30916465-363B1859-7CBD-48AA-B699-551D1675765EQ34143140-D330CE6A-A988-41BF-B6DF-638B4420E039Q38090897-FC49A620-B6E8-4EED-917C-752F7FC0929EQ38608632-2DAC431B-F5BA-4365-8555-4AFF9A7A4ACAQ39958094-5DE168AD-30D6-4C6F-A97F-9532D3951FABQ40616106-831F94CA-29FC-4E06-A506-E55DF634E9A3Q51086024-29AE9F55-FF0A-40E6-91ED-3C75526AC560
P2860
Escalation strategies for combination therapy Phase I trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Escalation strategies for combination therapy Phase I trials.
@en
Escalation strategies for combination therapy Phase I trials.
@nl
type
label
Escalation strategies for combination therapy Phase I trials.
@en
Escalation strategies for combination therapy Phase I trials.
@nl
prefLabel
Escalation strategies for combination therapy Phase I trials.
@en
Escalation strategies for combination therapy Phase I trials.
@nl
P2860
P356
P1476
Escalation strategies for combination therapy Phase I trials.
@en
P2860
P304
P356
10.1002/PST.1497
P577
2012-03-12T00:00:00Z